|
|
| (105 intermediate revisions by one user not shown) |
| Line 1: |
Line 1: |
| − | Atypical protein kinases lack sequence similarity to the ePK domain HMM profile, but
| + | __NOTOC__ |
| − | have been shown experimentally to have protein kinase activity, or are clear homologs of
| + | [[kinase classification|Kinase Classification]]: [[Kinase_Group_Atypical|Atypical Group]] |
| − | aPKs with demonstrated protein kinase activity. All aPK families are small, several
| + | |
| − | having just one member in vertebrates, and none in invertebrates. Other aPK families
| + | |
| − | may remain to be discovered by biochemical methods, but since most atypical families
| + | |
| − | are small, and most biochemically-discovered kinases are ePKs, it is unlikely that many
| + | |
| − | new atypical kinases will be discovered.. Conversely, some of these aPKs may be false
| + | |
| − | positives, if the reports of kinase activity are not correct.
| + | |
| | | | |
| | + | The Atypical protein kinases (aPK) group is now split into several structural categories. All aPKs lack sequence similarity to the ePK domain HMM profile, but have been shown experimentally to have protein kinase activity or are clear homologs of other aPKs. All eukaryotic aPK families are small, several having just one member in vertebrates, and none in invertebrates. Other aPK families may remain to be discovered by biochemical methods, but since most atypical families are small, and most biochemically-discovered kinases are ePKs, it is unlikely that many new atypical kinases will be discovered. Conversely, some of these aPKs may be false positives, if the reports of kinase activity are not correct. |
| | | | |
| − | ===Structural homologs of ePKs===
| |
| − | The following families have either crystal structures or predicted structures and catalytic mechanisms in common with the ePK domain, even though they have only residual similarity with ePKs
| |
| | | | |
| | + | ==Structural homologs of ePKs== |
| | + | Several kinases previously defined as "Atypical" are now known to share the same [[PKL]] fold and catalytic mechanism as ePKs. These have been reclassified to a new group, called [[Kinase_Group_PKL|PKL]]. |
| | | | |
| − | ====Alpha Kinases ====
| |
| − | The progenitors of this family are the myosin heavy chain kinases (MHCKs) of
| |
| − | Dictyostelium discoideum. While these are evolutionarily restricted, they are similar to
| |
| − | the eukaryotic elongation factor 2 kinase (eEF2K) found in most eukaryotes. Several
| |
| − | other mammalian genes have been found to be homologous to these, including the
| |
| − | channel kinases Chak1 and Chak2, which are multi-pass transmembrane proteins which
| |
| − | act as kinases and as ion channels. Crystal structure of the CHAK1 gene (Yamaguchi et
| |
| − | al, 2001) shows some structural similarity to the ePK domain fold, and catalytic activity
| |
| − | has been demonstrated for many members of this family.
| |
| | | | |
| − | ====ABC1/ADCK (ABC1 domain containing kinase) ==== | + | ==Structural Homologs of other kinase enzymes== |
| − | This conserved family was identified as putative kinases by sequence alignment methods
| + | |
| − | (Psi-Blast and HMMs) which show a domain that is weakly similar to the ePK domain,
| + | |
| − | with particular conservation of the most conserved catalytic motifs. Their kinase
| + | |
| − | similarity was first published by Leonard et al in 1998. Despite the lack of overall
| + | |
| − | sequence conservation with the ePK domain, these kinases contain candidates for the
| + | |
| − | most conserved kinase motifs, including the VAIK catalytic motif (VAVK, VAMK), the
| + | |
| − | DFG motif, and a QTD motif that may take the place of the HRD motif.
| + | |
| | | | |
| | + | ====[[Kinase_Family_PDHK|PDHK]]: Pyruvate Dehydrogenase Kinases==== |
| | + | This family of mitochondrial kinases contains a domain which is similar to prokaryotic histidine kinases, but has been shown biochemically to phosphorylate serine rather than histidine. Crystal structures confirm that the PDHK domain fold is similar to that of histidine kinases, distinct from the ePK domain <cite>Machius, Steussy</cite>. |
| | | | |
| − | ====PIKK – Phosphatidyl inositol 3’ kinase-related kinases==== | + | ====[[Kinase_Group_NDK|NDK]]: Nucleoside diphosphate Kinases==== |
| − | This family contains a phosphatidyl inositol 3,4, kinase domain (PI34K or PI3K), flanked | + | This universal group is known to phosphorylate NDPs to make NTPs, using a phospho-histidine intermediate, but has also been reported to have protein kinase activity in mammals, Drosophila and ciliates. |
| − | by a N-terminal FAT domain and a C-terminal FATC domain (Bosotti et al, 2000). Five
| + | |
| − | of the six human members of this family have experimentally verified protein kinase
| + | |
| − | activity and probably do not function as phosphatidyl inositol kinases. Multiple sequence | + | |
| − | alignment shows that the PI34K domains of PIKKs form a distinct domain subfamily.
| + | |
| − | The PI34K domain is structurally related to the ePK domain; a structural alignment of
| + | |
| − | ePK and PI34K domains shows similar structure and conservation of most of the
| + | |
| − | catalytically conserved residues, including the 'catalytic' K, the DFG motif and the HRD
| + | |
| − | motif (modified to DRH) (see for instance Walker et al, 1999).
| + | |
| | | | |
| | + | ====[[Kinase_Group_PyK|PyK]]: Pyruvate Kinase==== |
| | + | Human Pyruvate Kinase M2 (PKM2) phosphorylates ADP in a key step of glycolysis. Recent findings indicate that PKM2 also has protein tyrosine kinase activity, and possibly histidine kinase activity that is tied to cell proliferation regulation in cancer. No other form of pyruvate kinase has been implicated as a protein kinase. |
| | | | |
| − | ====RIO ====
| |
| − | This family has 3 clear subfamilies, with one member of each in fly, worm and human.
| |
| − | Yeast has two members (in the RIO1 and RIO2 subfamilies) and the fungus Aspergillus
| |
| − | nidulans has a member of the third subfamily, RIO3. Homologs are also present in
| |
| − | several archeal genomes. Yeast RIO1 was recently published to have serine kinase
| |
| − | activity by Angermayr et al (2002). The sequences do not align with the eukaryotic
| |
| − | protein kinase domain, but many of the catalytic residues are strongly conserved in the
| |
| − | RIO family, and overall structural similarity to ePKs has been predicted by Leonard et al
| |
| − | (1998)
| |
| | | | |
| | + | ==[[Kinase_Group_SAPPK|SAPPK]]: Structurally Atypical Putative Protein Kinases== |
| | + | Several proteins have reported protein kinase biochemical activity but are not members of any known kinase fold or have a known mechanism of phosphotransfer. Most have only one or a few papers supporting their kinase activity. Since some proteins (see below) are now thought to be non-kinases, despite initial supporting evidence, it may be that many of these proteins are not bona fide kinases, but can bind tightly to other kinases and so show activity. Many are known to autophosphorylate but not transphosphorylate, suggesting that if they are kinases, they have a limited substrate range. |
| | | | |
| | | | |
| − | ===Protein Kinases with no structural similarity to ePKs===
| |
| | | | |
| − | ====A6==== | + | === References === |
| − | This family consists of human A6 and A6r genes, along with homologs in fly, worm and
| + | <biblio> |
| − | yeast. A6 was first cloned as a phospho-protein by Beeler et al (1994), who demonstrated
| + | #Machius pmid=11562470 |
| − | tyrosine kinase activity by bacterial expression A6 fusion protein in an in vitro kinase
| + | #Steussy pmid=11483605 |
| − | activity. A6r was discovered by Rohwer et al (1999) by two-hybrid interaction with PKC
| + | </biblio> |
| − | zeta; they show that both A6 and A6r bind ATP, however, they failed to see kinase
| + | |
| − | activity by either protein. To the best of our knowledge, only one report supports the A6
| + | |
| − | family being a family of protein kinases.
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | ====PDK - Pyruvate Dehydrogenase Kinases====
| + | |
| − | This family of mitochondrial kinases contains a domain which is similar to prokaryotic
| + | |
| − | histidine kinases, but has been biochemically to phosphorylate serine rather than
| + | |
| − | histidine. Crystal structures (Machius et al, 2001, Steussy et al, 2001) confirm that the
| + | |
| − | PDK domain fold is similar to that of histidine kinases and Hsp90, and is distinct from
| + | |
| − | the ePK domain.
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | ====BRD - Bromodomain Kinases====
| + | |
| − | This family consists of the BRD2 (RING3) kinase and homologs in human and model
| + | |
| − | organisms. Dennis and Green (1996) first identified BRD2 as an autophosphorylating
| + | |
| − | nuclear-specific protein in Hela extracts. Recombinant BRD2 expressed in E. coli
| + | |
| − | showed kinase activity in an in vitro assay, which was abolished by mutation of the
| + | |
| − | putative catalytic lysine (K578A). The kinase activity was only seen when the purified
| + | |
| − | recombinant protein was first incubated with Hela cell extract and repurified, possibly
| + | |
| − | due to the need for activation of BRD2 by phosphorylation by another kinase.
| + | |
| − | Recombinant BRD2 purified from COS cells also showed in vitro kinase activity, without
| + | |
| − | the need for an activation step. Alignment of BRD2 with its human homologs (BRDT,
| + | |
| − | BRD3, BRD4), Drosophila fsh and an anonymous worm homolog shows the presence of
| + | |
| − | two bromodomains, and a third conserved region, which contains some similarity to the
| + | |
| − | ePK domain by secondary structure prediction (I. Grigoriev, unpublished).
| + | |
| − | | + | |
| − | | + | |
| − | ====TAF – TATA binding factor associated factors====
| + | |
| − | TAF1 (TAF II-250) is a component of the basal transcriptional machinery, and exists as a
| + | |
| − | single copy gene in all fully-sequenced eukaryotes. It has no close homologs. Dikstein et
| + | |
| − | al (1996) report that TAF1 is a protein kinase and contains two regions which can
| + | |
| − | independently phosphorylate the basal transcription factor RAP74. In vitro kinase assays
| + | |
| − | were carried out with immunopurified TFIID from Hela cells or with cloned TAF1
| + | |
| − | transfected into insect Sf9 cells or E. coli. Deletion mapping showed that two
| + | |
| − | independent regions, each less than 470 AA long had kinase activity, though neither had
| + | |
| − | significant sequence similarity to each other, to protein kinases, or to any other proteins.
| + | |
| − | Later studies (Solow et al, 2001, O’Brien and Tijan, 1998) confirm the result and perform
| + | |
| − | a finer mapping of the N-terminal kinase region. In 2002, Wang and Page revelated the
| + | |
| − | presence of TAF1L, a retrotransposed copy of TAF1 present in human and old-world
| + | |
| − | primates, which is expressed during spermatogenesis and substitutes for TAF1 in a
| + | |
| − | cellular assay.
| + | |
| − | | + | |
| − | | + | |
| − | ====BCR ====
| + | |
| − | Best known as the fusion partner of the Abl kinase in chronic myologenous leukemia, the
| + | |
| − | BCR gene itself also has protein kinase activity. Maru and Witte (1991) showed that
| + | |
| − | highly-purified BCR has auto- and trans-phosphorylation activities, and later mapped
| + | |
| − | cysteines and tyrosines that were critical for kinase activity. The kinase domain appears
| + | |
| − | to be a recent addition to the protein: the human ABR gene is about 70% identical in AA
| + | |
| − | sequence, but lacks the N-terminal putative kinase domain. The Drosophila gene
| + | |
| − | EG:23E12.2 (gi|7289304) also lacks the N-terminal putative kinase domain, but is 36%
| + | |
| − | identical over 750 AA in the C-terminus. The region conserved between these three
| + | |
| − | proteins includes a GTPase activator domain.
| + | |
| − | | + | |
| − | | + | |
| − | ====FASTK====
| + | |
| − | The human Fas-activated s/t kinase (FASTK) was characterised by Tian et al (1995) as a
| + | |
| − | kinase which was dephosphorylated and activated by Fas-mediated apoptosis. The
| + | |
| − | nuclear TIA-1 RNA-binding protein, a putative apoptosis effector, was identified as a
| + | |
| − | substrate. Differential expression of FASTK in apoptotic cells has also been reported by
| + | |
| − | Brutsche et al (2001). A close mouse ortholog is known (NP_148936.1), with 89% AA
| + | |
| − | identity. Two other very distant putative mammalian homologs have been sequenced, but
| + | |
| − | with ~27% identity between these genes, are not close enough to confidently assign a
| + | |
| − | kinase function to them.
| + | |
| − | | + | |
| − | | + | |
| − | ====G11====
| + | |
| − | This family consists of a single gene called G11 or STK19, which was shown by Gomez-
| + | |
| − | Escobar et al (1998). to have serine/threonine kinase activity against alpha casein and
| + | |
| − | histone, showed ATP-binding function and identified a putative catalytic lysine required
| + | |
| − | for function (unlike ePKs, this lysine is near the C-terminal end of the protein). The G11
| + | |
| − | protein was made in transfected insect or COS-7 cells and immunopreciptated, so it
| + | |
| − | remains possible that the kinase activity was due to a tightly bound protein.
| + | |
| − | Clear homologs are found in rat and mouse (~85% AA identity throughout), and a
| + | |
| − | divergent putative homolog fragment has been sequenced in zebrafish (45% identity over
| + | |
| − | 57 AA), but no obvious homolog has been seen in any other organism.
| + | |
| − |
| + | |
| − | ====TIF1 – Transcriptional Intermediary Factor 1 family====
| + | |
| − | A family of three Transcriptional Intermediary Factor 1 genes (TIF1a,b,g), of which
| + | |
| − | TIF1a has been shown to be a protein kinase (Fraser at al, 1998); the two other genes are
| + | |
| − | similar across their full length and so also likely to be kinases. A single TIF1 exists in the
| + | |
| − | Drosophila and mosquito genomes but not in C. elegans. Autophosphorylation activity
| + | |
| − | was detected in immunopurified, bacculovirus-produced protein. Life the TAFs, TIFs are
| + | |
| − | involved in the transcriptional machinery, and are though to phorphorylate several other
| + | |
| − | TATA-associated factors. Also similar to the TAFs and to BRD kinases, the TIFs contain
| + | |
| − | bromodomains, suggesting that they may be in some way inovlved in the kinase functions
| + | |
| − | of these proteins. A fourth putative member of this family exists in human, known as
| + | |
| − | KIAA0298 (Genbank sequence gi|13509324). However, it is divergent in regions that are
| + | |
| − | conserved between the other TIF1 family members. It may therefore not have conserved
| + | |
| − | the kinase sequence or activity and has not been inlcluded in our kinase catalog.
| + | |
| − |
| + | |
| − | ====H11====
| + | |
| − | The H11 gene is a homolog of the ICP10 gene of Herpes simpex virus, both of which
| + | |
| − | have been indicated to have kinase activity (Nelson et al, 1996, Smith et al, 2000). H11
| + | |
| − | kinase activity was demonstrated in protein immnopurified from bacterial and eukaryotic
| + | |
| − | expression systems. The kinase activity was lost when a putative catlytic lysine was
| + | |
| − | mutated. Smith et al noted weak similaritites between H11 and the FASTK atypical
| + | |
| − | kinase, but it is not known if these are significant. H11 belongs to the HSP20/Alpha
| + | |
| − | Crystallin family of proteins, and has a number of close and moderate homologs. Since
| + | |
| − | the kinase region hasn’t been mapped in this gene, it was not possible to confidently say
| + | |
| − | if any of these homologs also have kinase activity, so only H11 has been included in the
| + | |
| − | kinome catalog.
| + | |
| − |
| + | |
| − |
| + | |
| − | ===References===
| + | |
| − |
| + | |
| − | Angermayr, M., A. Roidl, et al. (2002). "Yeast Rio1p is the founding member of a novel
| + | |
| − | subfamily of protein serine kinases involved in the control of cell cycle
| + | |
| − | progression." Mol Microbiol 44(2): 309-24.
| + | |
| − | | + | |
| − | Beeler, J. F., W. J. LaRochelle, et al. (1994). "Prokaryotic expression cloning of a novel
| + | |
| − | human tyrosine kinase." Mol Cell Biol 14(2): 982-8.
| + | |
| − | | + | |
| − | Bosotti, R., A. Isacchi, et al. (2000). "FAT: a novel domain in PIK-related kinases."
| + | |
| − | Trends Biochem Sci 25(5): 225-7.
| + | |
| − | | + | |
| − | Brutsche, M. H., I. C. Brutsche, et al. (2001). "Apoptosis signals in atopy and asthma
| + | |
| − | measured with cDNA arrays." Clin Exp Immunol 123(2): 181-7.
| + | |
| − | Denis, G. V. and M. R. Green (1996). "A novel, mitogen-activated nuclear kinase is
| + | |
| − | related to a Drosophila developmental regulator." Genes Dev 10(3): 261-71.
| + | |
| − | Dikstein, R., S. Ruppert, et al. (1996). "TAFII250 is a bipartite protein kinase that
| + | |
| − | phosphorylates the base transcription factor RAP74." Cell 84(5): 781-90.
| + | |
| − | Gomez-Escobar, N., C. F. Chou, et al. (1998). "The G11 gene located in the major
| + | |
| − | histocompatibility complex encodes a novel nuclear serine/threonine protein
| + | |
| − | kinase." J Biol Chem 273(47): 30954-60.
| + | |
| − | Leonard, C. J., L. Aravind, et al. (1998). "Novel families of putative protein kinases in
| + | |
| − | bacteria and archaea: evolution of the "eukaryotic" protein kinase superfamily."
| + | |
| − | Genome Res 8(10): 1038-47.
| + | |
| − | Machius, M., J. L. Chuang, et al. (2001). "Structure of rat BCKD kinase: nucleotide-
| + | |
| − | induced domain communication in a mitochondrial protein kinase." Proc Natl
| + | |
| − | Acad Sci U S A 98(20): 11218-23.
| + | |
| − | Maru, Y. and O. N. Witte (1991). "The BCR gene encodes a novel serine/threonine
| + | |
| − | kinase activity within a single exon." Cell 67(3): 459-68.
| + | |
| − | Nelson, J. W., J. Zhu, et al. (1996). "ATP and SH3 binding sites in the protein kinase of
| + | |
| − | the large subunit of herpes simplex virus type 2 of ribonucleotide reductase
| + | |
| − | (ICP10)." J Biol Chem 271(29): 17021-7.
| + | |
| − | O'Brien, T. and R. Tijan (1998). "Functional Analysis of the Human TAFII-250 N-
| + | |
| − | terminal Kinase Domain." Molecular Cell 1: 905-911.
| + | |
| − | Rohwer, A., W. Kittstein, et al. (1999). "Cloning, expression and characterization of an
| + | |
| − | A6-related protein." Eur J Biochem 263(2): 518-25.
| + | |
| − | Smith, C. C., Y. X. Yu, et al. (2000). "A novel human gene similar to the protein kinase
| + | |
| − | (PK) coding domain of the large subunit of herpes simplex virus type 2
| + | |
| − | ribonucleotide reductase (ICP10) codes for a serine-threonine PK and is expressed
| + | |
| − | in melanoma cells." J Biol Chem 275(33): 25690-9.
| + | |
| − | Solow, S., M. Salunek, et al. (2001). "Taf(II) 250 phosphorylates human transcription
| + | |
| − | factor IIA on serine residues important for TBP binding and transcription
| + | |
| − | activity." J Biol Chem 276(19): 15886-92.
| + | |
| − | Steussy, C. N., K. M. Popov, et al. (2001). "Structure of pyruvate dehydrogenase kinase.
| + | |
| − | Novel folding pattern for a serine protein kinase." J Biol Chem 276(40): 37443-
| + | |
| − | 50.
| + | |
| − | Tian, Q., J. Taupin, et al. (1995). "Fas-activated serine/threonine kinase (FAST)
| + | |
| − | phosphorylates TIA-1 during Fas-mediated apoptosis." J Exp Med 182(3): 865-
| + | |
| − | 74.
| + | |
| − | Walker, E. H., O. Perisic, et al. (1999). "Structural insights into phosphoinositide 3-
| + | |
| − | kinase catalysis and signalling." Nature 402(6759): 313-20.
| + | |
| − | Wang, P. J. and D. C. Page (2002). "Functional substitution for TAF(II)250 by a
| + | |
| − | retroposed homolog that is expressed in human spermatogenesis." Hum Mol
| + | |
| − | Genet 11(19): 2341-6.
| + | |
| − | Yamaguchi, H., M. Matsushita, et al. (2001). "Crystal structure of the atypical protein
| + | |
| − | kinase domain of a TRP channel with phosphotransferase activity." Mol Cell 7(5):
| + | |
| − | 1047-57.
| + | |
The Atypical protein kinases (aPK) group is now split into several structural categories. All aPKs lack sequence similarity to the ePK domain HMM profile, but have been shown experimentally to have protein kinase activity or are clear homologs of other aPKs. All eukaryotic aPK families are small, several having just one member in vertebrates, and none in invertebrates. Other aPK families may remain to be discovered by biochemical methods, but since most atypical families are small, and most biochemically-discovered kinases are ePKs, it is unlikely that many new atypical kinases will be discovered. Conversely, some of these aPKs may be false positives, if the reports of kinase activity are not correct.
Several kinases previously defined as "Atypical" are now known to share the same PKL fold and catalytic mechanism as ePKs. These have been reclassified to a new group, called PKL.
This family of mitochondrial kinases contains a domain which is similar to prokaryotic histidine kinases, but has been shown biochemically to phosphorylate serine rather than histidine. Crystal structures confirm that the PDHK domain fold is similar to that of histidine kinases, distinct from the ePK domain [1, 2].
This universal group is known to phosphorylate NDPs to make NTPs, using a phospho-histidine intermediate, but has also been reported to have protein kinase activity in mammals, Drosophila and ciliates.
Human Pyruvate Kinase M2 (PKM2) phosphorylates ADP in a key step of glycolysis. Recent findings indicate that PKM2 also has protein tyrosine kinase activity, and possibly histidine kinase activity that is tied to cell proliferation regulation in cancer. No other form of pyruvate kinase has been implicated as a protein kinase.
Several proteins have reported protein kinase biochemical activity but are not members of any known kinase fold or have a known mechanism of phosphotransfer. Most have only one or a few papers supporting their kinase activity. Since some proteins (see below) are now thought to be non-kinases, despite initial supporting evidence, it may be that many of these proteins are not bona fide kinases, but can bind tightly to other kinases and so show activity. Many are known to autophosphorylate but not transphosphorylate, suggesting that if they are kinases, they have a limited substrate range.
